Top Pharmaceutical Stocks Worth Watching – May 18th

Eli Lilly and Company, D-Wave Quantum, and Novo Nordisk A/S are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of publicly traded companies engaged in the research, development, manufacturing, and marketing of medicinal drugs and therapies. Investors buy these equities to gain exposure to the biotech and healthcare sectors, hoping to profit from breakthroughs in drug discovery, regulatory approvals, and patent-protected sales. Because their performance often hinges on clinical trial results and government regulations, pharmaceutical stocks can exhibit higher volatility and unique risk–reward profiles compared with broader market indices. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Eli Lilly and Company stock traded up $23.94 on Friday, hitting $757.23. 4,632,057 shares of the stock traded hands, compared to its average volume of 3,599,113. Eli Lilly and Company has a 1 year low of $677.09 and a 1 year high of $972.53. The firm has a market cap of $717.65 billion, a P/E ratio of 64.67, a price-to-earnings-growth ratio of 1.40 and a beta of 0.48. The company has a current ratio of 1.15, a quick ratio of 0.97 and a debt-to-equity ratio of 2.00. The business’s fifty day simple moving average is $797.84 and its 200 day simple moving average is $805.85.

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

Shares of D-Wave Quantum stock traded up $1.28 during trading on Friday, hitting $12.31. The company’s stock had a trading volume of 111,467,964 shares, compared to its average volume of 38,328,543. D-Wave Quantum has a 52 week low of $0.75 and a 52 week high of $12.66. The company has a market capitalization of $3.59 billion, a PE ratio of -29.31 and a beta of 0.90. The company has a fifty day simple moving average of $8.00 and a two-hundred day simple moving average of $6.16.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NVO traded down $1.81 during midday trading on Friday, reaching $64.35. The company’s stock had a trading volume of 18,941,653 shares, compared to its average volume of 6,578,529. Novo Nordisk A/S has a 1 year low of $57.00 and a 1 year high of $148.15. The stock’s 50-day moving average is $67.31 and its 200-day moving average is $84.38. The firm has a market capitalization of $288.75 billion, a price-to-earnings ratio of 19.56, a PEG ratio of 0.90 and a beta of 0.65. The company has a current ratio of 0.74, a quick ratio of 0.55 and a debt-to-equity ratio of 0.62.